Who We Are
Can speech therapy help people who stutter become more fluent, confident communicators?
Yes, speech therapy can help!
Stuttering is a complex and frustrating speech disorder, especially for children and teens.
Effective treatment requires skills of an experienced clinician. Intervention involves not just the person who stutters but the significant people in the speaker’s life as well.
Kathy Henderson Swiney, CCC/SLP; BCS-F, has earned specialty recognition in fluency disorders through the American Speech-Language-Hearing Association (ASHA). Of the 190,000 ASHA members, less than 200 clinicians have this distinction. See American Board of Fluency and Fluency Disorders at StutteringSpecialists.org
Our Philosophy:
“Stuttering affects interpersonal relationships and reminds us that intervention is not just with a person who stutters, but with all people within the communication network. …Working with people who stutter is a responsibility of considerable magnitude.” — David. A. Shapiro (1999)
Kathy Henderson Swiney
Stuttering Specialist
MA, CCC-SLP, BCS-F
Board Certified Specialist in Stuttering – ASHA
• Lidcombe Program Provider Early Stuttering Intervention
• SpeechEasy Device Premiere Provider
Memberships:
• American Speech-Language Hearing Association
• Texas Speech-Language Hearing Association
• International Fluency Association (IFA)
• International Cluttering Association (ICA)
Support Group Sponsor:
• Children and Teens Who Stutter
Committee Member:
• Stuttering Association for the Young (SAY)
Exciting research on the treatment of stuttering is being conducted in Houston under the direction of Dr. David B. Rosenfield. Anyone can make a donation to the lab. These are tax-deductible and funds are used for research and the institution will provide a tax-deductible receipt.
Donations should be made payable to:
David B. Rosenfield, M.D.
Speech and Language Center, Houston Methodist Hospital
6560 Fannin Street, Suite 802
Houston, Texas 77030
People should not think that a donation is payment for treatment.
The treatment remains experimental as the team secures funding. If people are interested supporting the lab along the way, Dr. Rosenfield welcomes their support and would be happy to speak with interested parties.
